Article info
PDFBrief report
Distress, disease, desire: perspectives on the medicalisation of premature ejaculation
- Correspondence to Dr Ylva Söderfeldt, Max Planck Institute for the History of Science, Boltzmannstraße 22, 141 95 Berlin, Germany; ylva.soderfeldt{at}gmail.com
Citation
Distress, disease, desire: perspectives on the medicalisation of premature ejaculation
Publication history
- Received November 12, 2015
- Revised February 10, 2017
- Accepted March 6, 2017
- First published March 23, 2017.
Online issue publication
January 04, 2018
Article Versions
- Previous version (23 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Lidocaine/prilocaine spray for premature ejaculation
- ▼Dapoxetine for premature ejaculation
- A practical approach to assessing and managing sexual dysfunction in multiple sclerosis
- Sexual dysfunction and commonly used drugs in neurology
- Marcel Waldinger: neuropsychiatrist and researcher who defined premature ejaculation
- What's new in the other general journals
- Secular trends in self reported sexual activity and satisfaction in Swedish 70 year olds: cross sectional survey of four populations, 1971-2001
- Sexual dysfunction in men with type 2 diabetes
- Assessing and managing male sexual problems
- Sparing the doctor’s blushes: the use of sexually explicit films for the purpose of Sexual Attitude Reassessment (SAR) in the training of medical practitioners in Britain during the 1970s